Knowledge of Cervical Cancer Screening Among Women
CHAPTER ONE
Objective of the Study
The main objective of this study is to investigated knowledge of cervical cancer screening among women. The specific objectives include to:
- Assess the level of awareness and knowledge about cervical cancer and its screening methods among women.
- Identify factors influencing women’s participation in cervical cancer screening programs.
- Evaluate the impact of socio-demographic factors on women’s knowledge and participation in cervical cancer screening.
CHAPTER TWO
LITERATURE REVIEW
Conceptual Review
Cervical Cancer
Cervical cancer is a malignancy that originates from the epithelial cells lining the cervix uteri, which connects the vagina and the uterus. It primarily manifests as squamous cell carcinoma, arising from the squamous epithelial cells, or adenocarcinoma, originating from glandular cells (World Health Organization, 2022). These types represent the major forms of cervical cancer, though rarer types, such as adenosquamous carcinoma and small cell carcinoma, also occur. The disease’s development is largely driven by persistent infection with high-risk types of human papillomavirus (HPV), particularly HPV types 16 and 18 (World Health Organization, 2020). This persistent infection induces cellular changes in the cervix that can progress to cancer if untreated.
The aetiology of cervical cancer is strongly linked to HPV infection, which is transmitted through sexual contact (Nene et al., 2021). Other risk factors include smoking, which can exacerbate the carcinogenic effects of HPV, immunosuppression, and having multiple sexual partners (Zibako et al., 2021). Additionally, socioeconomic factors such as limited access to healthcare services and low educational attainment are significant contributors to the risk of developing cervical cancer (Wright et al., 2022). Women with these risk factors are at higher risk of both contracting HPV and experiencing progression to cancerous lesions.
Globally, cervical cancer remains a major health challenge, ranking as the fourth most common cancer among women and the fourth leading cause of cancer-related deaths in low- and middle-income countries (Khidzir et al., 2018). The incidence rates vary significantly by region, with sub-Saharan Africa experiencing the highest rates of cervical cancer, largely due to inadequate screening and treatment facilities (Ruddies et al., 2020). In contrast, incidence rates are considerably lower in high-income countries where robust screening programs are in place, such as Pap smears and HPV testing.
The impact of cervical cancer on women’s health is profound, as it not only affects physical health but also has significant psychological and social repercussions. Women diagnosed with cervical cancer may experience pain, discomfort, and significant alterations in their quality of life (Motavalli et al., 2018). The disease can lead to substantial emotional distress, impacting mental health and overall well-being. Additionally, advanced cervical cancer often results in infertility, sexual dysfunction, and increased mortality, contributing to a considerable burden on both individuals and healthcare systems (Tilahun et al., 2019).
Symptoms of cervical cancer can vary widely, ranging from early-stage asymptomatic cases to more severe manifestations such as abnormal vaginal bleeding, pelvic pain, and dyspareunia (painful intercourse) (Mulatu et al., 2023). As the disease progresses, symptoms may include more severe bleeding, weight loss, and signs of metastasis, such as swelling in the legs or pain in the lower back (Begoihn et al., 2019). Early-stage cervical cancer often goes unnoticed due to its asymptomatic nature, highlighting the importance of regular screening.
Diagnostic methods for cervical cancer typically involve a combination of pelvic examinations, Pap smears, and HPV testing. A Pap smear, or cervical cytology, detects precancerous cells and abnormalities in the cervix (Zhang et al., 2022). HPV testing, which identifies high-risk HPV strains, can further aid in the diagnosis and management of cervical cancer. If abnormalities are detected, a colposcopy may be performed to visually inspect the cervix and obtain biopsies for histopathological analysis (Oche et al., 2013). Staging of cervical cancer is determined through a combination of clinical examination, imaging studies, and histopathology, following the FIGO (International Federation of Gynecology and Obstetrics) staging system, which classifies the cancer from stage I (localized) to stage IV (advanced) (Omorogbe & Ehizemwogie, 2019).
Treatment options for cervical cancer depend on the stage and extent of the disease. Early-stage cancers may be treated with surgical procedures such as hysterectomy, cone biopsy, or cryotherapy (Rachana & Giri, 2019). Advanced cases often require a combination of surgery, radiation therapy, and chemotherapy (Heena et al., 2019). Prognosis varies based on the stage at diagnosis and the effectiveness of treatment, with early detection significantly improving survival rates (Alwahaibi et al., 2018). Continued advancements in treatment and early detection are crucial for improving outcomes and reducing the global burden of cervical cancer.
Cervical Cancer Screening
Cervical cancer screening is a vital public health measure aimed at early detection and prevention of cervical cancer. The primary goal of screening is to identify precancerous lesions and early-stage cancers before they progress to more severe stages, thereby reducing the incidence and mortality rates associated with cervical cancer (World Health Organization, 2022).
The two principal types of screening tests are the Pap smear and HPV testing. The Pap smear involves collecting cells from the cervix to detect abnormal changes that might indicate the presence of pre-cancerous conditions or cancer (Motavalli et al., 2018). HPV testing, on the other hand, identifies the presence of high-risk HPV types known to cause cervical cancer (Omorogbe & Ehizemwogie, 2019). Combining these tests, often referred to as co-testing, enhances the accuracy of cervical cancer detection and improves early intervention outcomes.
CHAPTER THREE
METHODOLOGY
Research Design
The study adopted a quantitative research design, characterized by its emphasis on quantifying data and analyzing numerical results to identify patterns and relationships. This approach was chosen because it allows for the systematic collection of data from a large number of respondents, which is essential for drawing statistically significant conclusions about the factors influencing cervical cancer screening. A quantitative survey design is well-suited for this research as it facilitates the examination of trends and correlations among variables, such as knowledge, attitudes, and practices related to cervical cancer screening (Saunders, Lewis, & Thornhill, 2019). This method provides a structured and objective way to gather data that can be analyzed to uncover insights into the prevalence and determinants of screening behaviors.
Population of the Study
The target population for this study comprised 1,200 female respondents who were selected from various demographic groups. This large population size was justified as it provides a broad representation of different segments within the community, enhancing the generalizability of the findings. The inclusion of a diverse sample ensures that the study captures a wide range of experiences and perceptions related to cervical cancer screening, which is crucial for identifying patterns and differences across various groups (Frankfort-Nachmias, Nachmias, & DeWaard, 2021). The comprehensive nature of this population allows for a more nuanced understanding of the factors influencing screening behaviors.
CHAPTER FOUR
DATA PRESENTATION, ANALYSIS AND DISCUSSION
CHAPTER FIVE
SUMMARY, CONCLUSION AND RECOMMENDATIONS
Summary of Findings
The study provides a comprehensive examination of cervical cancer awareness, knowledge, and participation among women. The results are derived from a structured questionnaire distributed to a sample of 120 respondents, of which 108 completed and returned the forms. The analysis of the data offers valuable insights into various aspects of cervical cancer screening and highlights key areas for improvement in public health strategies.
Firstly, the findings indicate a generally high level of awareness about cervical cancer among respondents. According to Table 4.6, 78.7% of participants affirmed their awareness of cervical cancer and its potential health impacts. This suggests that health education campaigns have successfully disseminated information about the disease to a significant portion of the population. However, the remaining 21.3% who either disagreed or were uncertain about their awareness indicate that there are still gaps in reaching all individuals. This subset underscores the need for more targeted educational efforts to ensure comprehensive awareness.
The respondents’ familiarity with various cervical cancer screening methods is also notably high, as shown in Table 4.7, with 76.8% of participants knowing about the available screening methods. This level of knowledge is promising but highlights the necessity for continued educational initiatives. Even though the majority are informed, a notable portion remains either unsure or misinformed about screening options, suggesting that educational programs should address specific knowledge gaps and reinforce existing information.
In terms of understanding the recommended frequency for cervical cancer screening, Table 4.8 reveals that 75% of respondents are aware of how often screening should occur. This is crucial for ensuring timely detection and treatment of cervical cancer. However, the fact that 9.2% of respondents are either uncertain or disagree on the recommended frequency indicates that more precise information needs to be provided to the public. Ensuring that individuals understand not only the importance but also the specifics of screening schedules is essential for effective prevention.
The benefits of early detection through cervical cancer screening are well recognized among respondents, with 78.7% understanding the advantages, as depicted in Table 4.9. This high level of awareness is a positive outcome, suggesting that public health messages about the importance of early detection are reaching a significant audience. Nonetheless, the 16.2% of respondents who do not fully grasp these benefits highlight the need for ongoing education to reinforce the importance of early detection and its impact on improving outcomes.
Access to healthcare facilities plays a crucial role in influencing participation in cervical cancer screening programs. As shown in Table 4.10, 76% of respondents believe that their ability to access healthcare facilities affects their decision to participate. This indicates that logistical barriers, such as proximity to healthcare services and transportation issues, are significant factors in determining whether individuals undergo screening. Addressing these barriers through improved healthcare infrastructure and outreach programs could enhance participation rates.
The cost of cervical cancer screening is another major factor affecting willingness to participate, as evidenced by Table 4.11. With 84.3% of respondents identifying cost as a significant barrier, it is clear that financial considerations are a major impediment to accessing screening services. Strategies to reduce financial barriers, such as offering subsidized screening programs or financial assistance, could significantly improve participation rates and ensure that cost is not a limiting factor for those in need of screening.
Recommendations from healthcare providers are also influential in the decision to participate in screening programs. Table 4.12 shows that 73.2% of respondents are swayed by healthcare professionals’ advice. This underscores the critical role that healthcare providers play in encouraging screening and educating patients about its importance. Ensuring that healthcare providers are well-informed and proactive in discussing screening options with patients could further enhance participation.
Personal beliefs and cultural attitudes impact screening participation, with 73.2% of respondents acknowledging this influence as per Table 4.13. This finding highlights the need for culturally sensitive educational materials and outreach programs that respect and address personal and cultural values. Tailoring public health messages to align with cultural attitudes and beliefs could help overcome resistance and increase participation in screening programs.
Socio-demographic factors, such as age, education, and socioeconomic status, also affect awareness and participation. Table 4.14 shows that 73.2% of respondents believe their age affects their awareness of cervical cancer. This suggests that educational messages should be age-appropriate and tailored to different age groups to maximize their effectiveness. Table 4.15 indicates that 56.5% of respondents think their level of education influences their knowledge about cervical cancer, emphasizing the need for targeted educational interventions for those with lower educational attainment. Additionally, Tables 4.16 and 4.17 highlight that socioeconomic status and income levels impact the ability to access and participate in screening programs. Addressing these socioeconomic barriers through financial assistance and improved access to services could help mitigate disparities in screening participation.
In summary, the study provides a detailed overview of cervical cancer awareness, knowledge, and screening participation. The findings underscore the effectiveness of current educational efforts while also identifying areas for improvement. Enhancing public health strategies by addressing financial barriers, improving access to healthcare facilities, tailoring educational materials to different demographics, and leveraging healthcare providers’ recommendations can lead to increased participation in cervical cancer screening programs and ultimately improve early detection and outcomes.
Conclusion
The results from the hypotheses tested reveal critical insights into cervical cancer awareness, knowledge, and screening participation. The data demonstrate that while there is a high level of awareness about cervical cancer and its screening methods, there remain significant barriers that affect participation. The hypotheses testing confirmed that socioeconomic factors, such as income and access to healthcare facilities, play a substantial role in influencing women’s decisions to participate in screening programs. The impact of cost on willingness to undergo screening was notably significant, highlighting financial barriers as a major obstacle. Additionally, the influence of healthcare provider recommendations and personal beliefs was also confirmed, emphasizing the importance of tailored educational efforts and culturally sensitive outreach.
The study underscores the need for targeted interventions to address these barriers. Improving access to affordable screening, enhancing healthcare provider engagement, and creating culturally appropriate educational materials can significantly increase participation rates. By addressing these factors, public health strategies can be more effective in promoting early detection and reducing cervical cancer incidence. Overall, the findings advocate for comprehensive approaches to overcoming barriers and improving screening participation among women.
Recommendations
Based on the research objectives, the following recommendations are proposed to enhance cervical cancer awareness and screening participation among women:
1.Increase Public Awareness Campaigns: Implement targeted awareness campaigns that educate women about cervical cancer and the importance of screening. These campaigns should focus on disseminating information through various media channels, community events, and healthcare providers. Emphasis should be placed on demystifying the screening process and highlighting the benefits of early detection.
2.Enhance Accessibility to Screening Services: Improve the availability and accessibility of cervical cancer screening services, particularly in underserved areas. This includes increasing the number of screening facilities, offering mobile screening units, and extending clinic hours to accommodate working women. Reducing physical and logistical barriers can help increase participation rates.
3.Subsidize Screening Costs: Develop programs to subsidize the cost of cervical cancer screening, especially for low-income and economically disadvantaged women. Financial assistance, sliding scale fees, or free screening programs can help alleviate cost-related barriers and encourage more women to undergo regular screening.
4.Train Healthcare Providers: Provide additional training for healthcare providers on effective communication strategies and culturally sensitive practices. Ensuring that providers are well-equipped to discuss cervical cancer screening with patients and address their concerns can lead to higher rates of screening uptake.
5.Strengthen Community Engagement: Collaborate with community organizations and local leaders to promote cervical cancer screening. Engaging trusted community figures and utilizing existing community networks can help to overcome cultural and personal barriers to screening. Tailoring educational messages to reflect community values and beliefs can also improve receptiveness.
6.Implement Regular Follow-Up and Reminders: Establish systems for regular follow-up and reminders for women due for screening. Automated reminder systems, follow-up phone calls, and personalized messages from healthcare providers can help ensure that women do not miss their scheduled screenings and maintain regular screening intervals.
Contribution to Knowledge
The research on cervical cancer awareness, screening participation, and socio-demographic influences offers significant contributions to knowledge in the field of public health and preventive care. First, the study provides a comprehensive understanding of the current level of awareness among women regarding cervical cancer and its screening methods. By revealing the gaps in knowledge and the variations in awareness across different demographic groups, the research underscores the need for targeted educational interventions. This information is crucial for designing effective public health campaigns and educational programs tailored to specific population needs.
Second, the study highlights key factors that influence women’s participation in cervical cancer screening programs. By identifying barriers such as cost, access to healthcare facilities, and the impact of personal beliefs, the research contributes valuable insights into the challenges women face. These findings are essential for developing strategies to enhance screening uptake, such as subsidizing costs and improving access, which can ultimately lead to increased early detection rates and better health outcomes.
Third, the research emphasizes the role of socio-demographic factors, including age, education, and socioeconomic status, in shaping women’s knowledge and participation in cervical cancer screening. The study’s results reveal how these factors impact women’s awareness and their likelihood to engage in screening activities. Understanding these relationships helps in crafting targeted interventions that address the specific needs of different demographic groups, thereby improving the overall effectiveness of cervical cancer prevention programs.
Fourth, the study’s findings on the impact of healthcare provider recommendations and personal beliefs provide a deeper understanding of the psychosocial factors influencing screening behaviors. The research demonstrates that recommendations from healthcare providers significantly impact women’s decisions to participate in screening programs, highlighting the need for healthcare professionals to play an active role in promoting screening. Additionally, addressing personal beliefs and cultural attitudes is crucial for overcoming resistance and encouraging more women to undergo regular screenings.
Finally, the research contributes to the development of evidence-based recommendations for improving cervical cancer screening programs. The study’s recommendations for increasing public awareness, enhancing accessibility, subsidizing costs, and training healthcare providers are grounded in empirical data, offering actionable strategies for policymakers and public health officials. By addressing the identified barriers and leveraging the insights gained from this research, stakeholders can implement more effective interventions that enhance cervical cancer screening rates and ultimately reduce the burden of cervical cancer.
References
- Abiodun, O. A., Fatungase, O. K., Olu-Abiodun, O. O., & et al. (2023). An assessment of women’s awareness and knowledge about cervical cancer and screening and the barriers to cervical screening in Ogun State, Nigeria. IOSR Journal of Dental and Medical Sciences, 10, 52–58. https://doi.org/10.9790/0853-1035258.
- Adoch, W., Garimoi, C. O., Scott, S. E., Okeny, G. G., Moodley, J., Komakech, H., & et al. (2020). Knowledge of cervical cancer risk factors and symptoms among women in a refugee settlement: A cross-sectional study in northern Uganda. Conflict and Health, 14(1), 1–9.
- Alwahaibi, N., Alsalami, W., Alramadhani, N., et al. (2018). Factors influencing knowledge and practice regarding cervical cancer and pap smear testing among Omani Women. Asian Pacific Journal of Cancer Prevention, 19(12), 3367–3374. https://doi.org/10.31557/APJCP.2018.19.12.3367
- American Cancer Association. (2021). Cervical cancer causes risk factors and prevention. Retrieved from https://www.cancer.org/cancer/cervical-cancer/about/what-is-cervical-cancer.html.
- Anyebe, E. E., Opaluwa, S. A., Muktar, H. M., et al. (2023). Knowledge and practice of cervical cancer screening amongst nurses in Ahmadu
- Bello University Teaching Hospital Zaria. Research on Humanities and Social Sciences, 4, 2225–0484.
- Begoihn, M., Mathewos, A., Aynalem, A., Wondemagegnehu, T., Moelle, U., Gizaw, M., & et al. (2019). Cervical cancer in Ethiopia–Predictors of advanced stage and prolonged time to diagnosis. Infectious Agents and Cancer, 14(1), 1–7.
- Beiske, B. (2017). Research methods: Uses and limitations of questionnaires, interviews and case studies. GRIN Verlag.
